Alglucosidase alfa
Lumizyme, Myozyme (alglucosidase alfa) is an enzyme pharmaceutical. Alglucosidase alfa was first approved as Lumizyme on 2006-03-28. It is used to treat glycogen storage disease type II in the USA. It has been approved in Europe to treat glycogen storage disease type II.
| Trade Name | Myozyme |
|---|---|
| Common Name | Alglucosidase alfa |
| Indication | glycogen storage disease type ii |
| Drug Class | Enzymes |
